Dr. Antoine Desilets (he/him), MD, MSc completed his medical training at McGill University in Montreal, followed by subspecialty training in medical oncology and hematology, with a focus on molecular diagnostics. He then pursued a three-year research fellowship at Memorial Sloan Kettering Cancer Center in New York, where he worked on emerging cancer therapeutics guided by molecular biomarkers, including tumor next-generation sequencing and liquid biopsies.

In 2024, Dr. Desilets joined the Centre hospitalier de l'Université de Montréal (CHUM) as a hematologist-oncologist specializing in the treatment of thoracic and head and neck malignancies. He is also Co-Director of the Guy Lafleur Precision Oncology Program and a regular researcher at the Cancer Axis of CRCHUM, with a particular interest in early-phase precision oncology trials, molecular biomarkers, and liquid biopsies.